ARCHIVES

Myriad In Partnership To Market Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Tafinlar Subgroup Data Shows Median OS of 20 Months

October 31, 2014

In Brief: O’Brien Will Leave USC To Become Medical School Dean At Creighton; DRCCA Adds New Staff Members

May 14, 1982

Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy

October 27, 1978

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Sunitinib Prolongs Survival In Poor Prognosis, Study Finds

July 31, 2009

In Brief: Foundation Funds Six Lung Cancer Studies; Schilsky Re-elected CALGB Chairman

November 19, 1999